CAS RN: 106266-06-2

Risperidone

  • Product code: SSC-008029
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 5g
  • Available purity: ≥97%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 106266-06-2
Pack Size Recorded Purity Available Qty Ship From Inquiry
5g ≥97% 0 Out of Stock Beijing Inquiry

106266-06-2 / 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one

risperidone | Risperdal | Risperdal Consta

Standard CAS: 106266-06-2 Multi CAS: Yes

Basic Information

CAS
106266-06-2
Multi CAS
Yes
Molecular Formula
C23H27FN4O2
Molecular Weight
410.500000
Exact Mass
410.211804
SMILES
CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
InChI
InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
InChIKey
RAPZEAPATHNIPO-UHFFFAOYSA-N
Synonyms
risperidone Risperdal Risperdal Consta Rispolept Rispolin

Physical Properties

Melting Point
170 °C
Physical Description
Solid
Appearance
White to slightly beige powder Crystals from dimethylformamide + propanol
State
Solid

Computed Properties

Structural Parameters

Heavy atom count
30
Aromatic heavy atom count
15
Fraction Csp3
0.52
Rotatable bonds
4
H-bond acceptors
6
Molar refractivity
112.26
TPSA
64.16

LogP / Solubility

WLOGP
3.59
MLOGP
3.18
XLogP3
2.7
Consensus LogP
3.16
Log S (ESOL)
-4.75
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.52
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.79
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.67

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3.5

Safety & Transport

Pictogram(s)
Acute Toxic Health Hazard Environmental Hazard
Signal
Danger
GHS Hazard Statements
H301 (99.3%): Toxic if swallowed [Danger Acute toxicity, oral] H331 (12.3%): Toxic if inhaled [Danger Acute toxicity, inhalation] H351 (12.3%): Suspected of causing cancer [Warning Carcinogenicity] H411 (19.2%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
Precautionary Statement Codes
P203, P261, P264, P270, P271, P273, P280, P301+P316, P304+P340, P316, P318, P321, P330, P391, P403+P233, P405, and P501

Get In Touch

Contact Us